109 results
Page 4 of 6
424B5
g9onv4ba2
5 Feb 21
Prospectus supplement for primary offering
5:26pm
424B5
nndnb bhvsc3p
3 Feb 21
Prospectus supplement for primary offering
5:12pm
8-K
EX-2.1
n3r3ym82ayi k76j7ssd
5 Jan 21
Entry into a Material Definitive Agreement
4:49pm
8-K
bowslkagdmp9skhr5n9
16 Sep 20
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
2uk34oonkb7rvcrwd
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
s316oh417
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
ue6e4ds
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
8-K
EX-99.1
6dqf gfdu940y
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
EX-1.1
ayimt ecmomc0fs2j572
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
424B5
zo82 yxatsd
16 Oct 19
Prospectus supplement for primary offering
5:25pm
424B5
qpw9ewpq2nm
15 Oct 19
Prospectus supplement for primary offering
4:51pm